PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:25 AM ET

Sponsor Check › Person

DF
No photo found yet (own website and image search run after this page is viewed)

David R. Fischell

Named as an officer, director or promoter on SEC Form D filings · NJ, CA, MD, MA · Nov 27, 2009 → Jan 2, 2018

8deals (issuers)
$288.5Mreported sold
489investors
72Form D filings
2009–2018years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

David R. Fischell is listed as an executive officer and director on 72 SEC Form D filings by 8 issuers between May 2009 and Jun 2026. Largest by amount reported sold: NeuroPace Inc (Mountain View, CA — other health care — 2011–2013; $72M reported sold to 26 investors), Ablative Solutions, Inc. (Wakefield, MA — other health care — 2011–2024; $54.5M reported sold to 149 investors), ADURO BIOTECH, INC. (Berkeley, CA — biotechnology — 2009; $51.4M reported sold to 28 investors), SVELTE MEDICAL SYSTEMS INC (New Providence, NJ — biotechnology — 2009–2013; $50.4M reported sold to 39 investors), Avertix Medical, Inc. (Eatontown, NJ — other health care — 2012–2024; $34.3M reported sold to 82 investors) and 3 more (all listed below).

What this means A repeat sponsor — 8 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $288.5M sold in total.

Listed alongside David Rosen (35 shared filings), Phillip D. Torrence (34 shared filings), Tim A. Fischell (29 shared filings), Robert E. Fischell (26 shared filings), Terry Lierman (16 shared filings) and 78 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared the newest 50 of 72 public filings for David R. Fischell and found 16 differences, 3 worth asking the sponsor about: Regulator action naming a team member: Rouzbeh “Ross” Haghighat; Behrouz “Bruce” Haghighat; Kirstyn Pearl; James Roberge; Seyedfarbod “Fabio” Sabzevari (Aug 22, 2025); Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for David R. Fischell has not run yet — it is #7,002 of 32,581 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched David R. Fischell..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

16 differences found between the filings for David R. Fischell — 3 worth asking about (compared the newest 50 of 72 filings on Oct 24, 2026; older filings not covered)

Worth asking · Aug 22, 2025

Regulator action naming a team member: Rouzbeh “Ross” Haghighat; Behrouz “Bruce” Haghighat; Kirstyn Pearl; James Roberge; Seyedfarbod “Fabio” Sabzevari (Aug 22, 2025)

An SEC litigation release dated Aug 22, 2025 names Ross Haghighat (listed on the same filings). Our match estimate: 80%. The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Rouzbeh “Ross” Haghighat; Behrouz “Bruce” Haghighat; Kirstyn Pearl; James Roberge; Seyedfarbod “Fabio” Sabzevari ↗Ross Haghighat — PartnerFacts page ↗
Sources
Note · Aug 14, 1995 – Dec 28, 1995

Bankruptcy case: Universal Bank v. Ghazarossian — filed Aug 14, 1995

United States Bankruptcy Court, C.D. California docket "Universal Bank v. Ghazarossian" filed Aug 14, 1995, closed Dec 28, 1995. Vartan E. Ghazarossian (listed on the same filings) is listed as Defendant ("Ghazarossian"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗Vartan E. Ghazarossian — PartnerFacts page ↗
Sources
Worth asking · Feb 8, 2018

Investor count went down between filings — eNeura, INC.

The Feb 8, 2018 filing reports 24 investors; the Feb 8, 2018 Form D/A reports 10 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Feb 8, 2018 ↗Form D/A (later) · Feb 8, 2018 ↗eNeura, INC. — PartnerFacts page ↗
Sources
Worth asking · Apr 4, 2013 – Oct 2, 2013

5 filings report more than 10% of the money raised going to insiders

36% of the money raised went to insiders — Ablative Solutions, Inc. · 17% of the money raised went to insiders — eNeura, INC. · 14% of the money raised went to insiders — Ablative Solutions, Inc. · 19% of the money raised went to insiders — Ablative Solutions, Inc. · 12% of the money raised went to insiders — eNeura, INC.

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Apr 4, 2013 ↗Ablative Solutions, Inc. — PartnerFacts page ↗Form D · Oct 2, 2013 ↗eNeura, INC. — PartnerFacts page ↗
Sources
Note · Feb 21, 2020

David R. Fischell appears on 1 deal that stopped filing before reaching its target

eNeura, INC. (last filing Feb 21, 2020; $15,000,000 sold of $31,117,692). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

eNeura, INC. — PartnerFacts page ↗
Sources
Note · Jul 30, 2021 – Aug 17, 2021

Form D filed 18 days after the first sale — Avertix Medical, Inc.

The filing says the first sale was Jul 30, 2021. The Form D was filed Aug 17, 2021 — 18 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 3 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Aug 17, 2021 ↗Avertix Medical, Inc. — PartnerFacts page ↗
Sources
Note · Dec 5, 2012 – Dec 26, 2024

28 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Ablative Solutions, Inc. (latest filing Dec 26, 2024) · No amendment in the last 12 months on an offering that may still be open — Avertix Medical, Inc. (latest filing Aug 14, 2024) · No amendment in the last 12 months on an offering that may still be open — Avertix Medical, Inc. (latest filing May 10, 2024) · No amendment in the last 12 months on an offering that may still be open — Ablative Solutions, Inc. (latest filing Jan 30, 2024) · No amendment in the last 12 months on an offering that may still be open — TETmedical, Inc. (latest filing Jun 13, 2023) · and 23 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Dec 26, 2024 ↗Ablative Solutions, Inc. — PartnerFacts page ↗Form D · Aug 14, 2024 ↗Avertix Medical, Inc. — PartnerFacts page ↗
Sources
Note · Sep 6, 2022 – Mar 1, 2023

David R. Fischell's role changed at Avertix Medical, Inc.: executive officer, director → director

The Sep 6, 2022 filing lists David R. Fischell as executive officer, director; the Mar 1, 2023 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Sep 6, 2022 ↗Form D · Mar 1, 2023 ↗David R. Fischell — PartnerFacts page ↗Avertix Medical, Inc. — PartnerFacts page ↗
Sources
Note · Jan 2, 2018 – Jan 8, 2019

David R. Fischell's role changed at Ablative Solutions, Inc.: executive officer, director → director

The Jan 2, 2018 filing lists David R. Fischell as executive officer, director; the Jan 8, 2019 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jan 2, 2018 ↗Form D · Jan 8, 2019 ↗David R. Fischell — PartnerFacts page ↗Ablative Solutions, Inc. — PartnerFacts page ↗
Sources
Note · Dec 13, 2012 – May 10, 2024

16 offerings changed their target amount between filings

Offering amount changed between filings — Avertix Medical, Inc. · Offering amount changed between filings — Ablative Solutions, Inc. · Offering amount changed between filings — Ablative Solutions, Inc. · Offering amount changed between filings — eNeura, INC. · Offering amount changed between filings — eNeura, INC. · and 11 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Nov 13, 2023 ↗Form D/A (later) · May 10, 2024 ↗Avertix Medical, Inc. — PartnerFacts page ↗Form D (earlier) · Apr 7, 2023 ↗
Sources
Note · Mar 12, 2015 – Mar 10, 2016

Minimum investment changed between filings — eNeura, INC.

The Mar 12, 2015 filing lists a minimum of $0; the Mar 10, 2016 Form D/A lists $10,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D/A (earlier) · Mar 12, 2015 ↗Form D/A (later) · Mar 10, 2016 ↗eNeura, INC. — PartnerFacts page ↗
Sources
Note · Dec 13, 2012 – Apr 11, 2013

David R. Fischell is written 2 different ways on the filings

listed as "David R. Fischell" on 22 filings (from Dec 13, 2012), and "David Fischell" on 28 filings (from Apr 11, 2013).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Dec 13, 2012 ↗Form D · Apr 11, 2013 ↗David R. Fischell — PartnerFacts page ↗
Sources
Note · Jun 13, 2023 – Jun 24, 2026

Industry group changed between filings — TETmedical, Inc.

"Other Health Care" (Jun 13, 2023); then "Biotechnology" (Jun 24, 2026).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jun 13, 2023 ↗Form D · Jun 24, 2026 ↗TETmedical, Inc. — PartnerFacts page ↗
Sources
Note · Apr 11, 2013 – Jan 3, 2014

Reported revenue range changed between filings — eNeura, INC.

"$1 - $1,000,000" (Apr 11, 2013); then "Decline to Disclose" (Jan 3, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 11, 2013 ↗Form D · Jan 3, 2014 ↗eNeura, INC. — PartnerFacts page ↗
Sources
Note · Aug 29, 2014 – Feb 1, 2021

5 address changes between filings

Address moved from San Jose, CA to Wakefield, MA — Ablative Solutions, Inc. · Address moved from Shrewsbury, NJ to Eatontown, NJ — Avertix Medical, Inc. · Address moved from Palo Alto, CA to San Jose, CA — Ablative Solutions, Inc. · Address moved from Kalamazoo, MI to Palo Alto, CA — Ablative Solutions, Inc. · Address moved from Sunnyvale, CA to Baltimore, MD — eNeura, INC.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Jan 8, 2019 ↗Form D/A · Feb 1, 2021 ↗Ablative Solutions, Inc. — PartnerFacts page ↗Form D · Dec 8, 2014 ↗
Sources
Note · Dec 13, 2012 – Jun 24, 2026

David R. Fischell is listed with 4 different address states: NJ, CA, MD, MA

NJ on 27 filings (Dec 13, 2012 to Jun 24, 2026); CA on 8 filings (Apr 11, 2013 to Jan 8, 2019); MD on 11 filings (Mar 12, 2015 to Nov 4, 2019); MA on 4 filings (Feb 1, 2021 to Dec 26, 2024).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Dec 13, 2012 ↗Form D · Apr 11, 2013 ↗Form D/A · Mar 12, 2015 ↗Form D/A · Feb 1, 2021 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 72 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

0 of 45 offerings report sales commissions; 0 report finder's fees; 12 report proceeds to related persons totalling $4,302,142. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 24, 2026 D
TETmedical, Inc.
File 021-588441
$0$0$0None listed on this filingEDGAR ↗
Dec 26, 2024 D
Ablative Solutions, Inc.
File 021-533347
$0$0$0None listed on this filingEDGAR ↗
Aug 14, 2024 D
Avertix Medical, Inc.
File 021-521481
$0$0$0None listed on this filingEDGAR ↗
May 10, 2024 D/A
Avertix Medical, Inc.
File 021-497064
$0$0$0None listed on this filingEDGAR ↗
Jan 30, 2024 D/A
Ablative Solutions, Inc.
File 021-478243
$0$0$0None listed on this filingEDGAR ↗
Jun 13, 2023 D
TETmedical, Inc.
File 021-484033
$0$0$0None listed on this filingEDGAR ↗
Mar 1, 2023 D
Avertix Medical, Inc.
File 021-474604
$0$0$0None listed on this filingEDGAR ↗
Sep 6, 2022 D
Avertix Medical, Inc.
File 021-458016
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Aug 17, 2021 D
Avertix Medical, Inc.
File 021-410274
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Feb 1, 2021 D/A
Ablative Solutions, Inc.
File 021-329913
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Nov 4, 2019 D
eNeura, INC.
File 021-352467
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Apr 1, 2019 D
Avertix Medical, Inc.
File 021-336135
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Mar 12, 2019 D/A
eNeura, INC.
File 021-235727
$0$0$500,000 (est.)None listed on this filingEDGAR ↗
Mar 12, 2019 D
eNeura, INC.
File 021-334592
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Jan 17, 2019 D
Avertix Medical, Inc.
File 021-330812
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Nov 26, 2018 D/A
eNeura, INC.
File 021-305141
$0$0$0None listed on this filingEDGAR ↗
Jan 2, 2018 D
Ablative Solutions, Inc.
File 021-302146
$0$0$0None listed on this filingEDGAR ↗
Jul 12, 2017 D/A
eNeura, INC.
File 021-275385
$0$0$0 (est.)None listed on this filingEDGAR ↗
Mar 1, 2017 D
Ablative Solutions, Inc.
File 021-281541
$0$0$0 (est.)None listed on this filingEDGAR ↗
Mar 10, 2016 D/A
eNeura, INC.
File 021-223836
$0$0$0 (est.)None listed on this filingEDGAR ↗
Nov 12, 2015 D
Ablative Solutions, Inc.
File 021-251091
$0$0$25,000 (est.)None listed on this filingEDGAR ↗
Jan 12, 2015 D/A
Ablative Solutions, Inc.
File 021-209426
$0$0$375,000 (est.)None listed on this filingEDGAR ↗
Dec 8, 2014 D
Avertix Medical, Inc.
File 021-229642
$0$0$0 (est.)
Proceeds will be used for, among other things, general corporate purposes including, but not limited to, executive salaries
None listed on this filingEDGAR ↗
Feb 21, 2014 D
eNeura, INC.
File 021-212314
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 3, 2014 D
eNeura, INC.
File 021-209183
$0$0$0 (est.)None listed on this filingEDGAR ↗
Dec 16, 2013 D/A
Avertix Medical, Inc.
File 021-188326
$0$0$0 (est.)
Proceeds will be used for, among other things, general corporate purposes including, but not limited to, executive salaries
None listed on this filingEDGAR ↗
Nov 7, 2013 D/A
Ablative Solutions, Inc.
File 021-194476
$0$0$375,000 (est.)None listed on this filingEDGAR ↗
Oct 2, 2013 D
eNeura, INC.
File 021-203875
$0$0$100,000 (est.)None listed on this filingEDGAR ↗
Aug 20, 2013 D/A
eNeura, INC.
File 021-194884
$0$0$272,500 (est.)None listed on this filingEDGAR ↗
Jul 9, 2013 D
NeuroPace Inc
File 021-199252
$0$0$0 (est.)
Proceeds will be used for general corporate purposes including, but not limited to, executive salaries
None listed on this filingEDGAR ↗
Jun 4, 2013 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-195730
$0$0$229,642 (est.)None listed on this filingEDGAR ↗
Dec 13, 2012 D
eNeura, INC.
File 021-188345
$0$0$100,000 (est.)None listed on this filingEDGAR ↗
Nov 9, 2012 D
eNeura, INC.
File 021-186778
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jun 26, 2012 D
Ablative Solutions, Inc.
File 021-180282
$0$0$500,000 (est.)None listed on this filingEDGAR ↗
Jun 21, 2012 D
SVELTE MEDICAL SYSTEMS INC
File 021-180116
$0$0$800,000 (est.)None listed on this filingEDGAR ↗
Mar 29, 2012 D/A
Ablative Solutions, Inc.
File 021-169312
$0$0$300,000 (est.)None listed on this filingEDGAR ↗
Feb 10, 2012 D
Ablative Solutions, Inc.
File 021-173267
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 24, 2012 D
Ablative Solutions, Inc.
File 021-172382
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 4, 2012 D
Ablative Solutions, Inc.
File 021-171150
$0$0$0 (est.)None listed on this filingEDGAR ↗
Dec 14, 2011 D
SVELTE MEDICAL SYSTEMS INC
File 021-170051
$0$0$0 (est.)None listed on this filingEDGAR ↗
Aug 30, 2011 D
NeuroPace Inc
File 021-165134
$0$0$0None listed on this filingEDGAR ↗
Jul 15, 2011 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-149681
$0$0$725,000 (est.)None listed on this filingEDGAR ↗
Dec 10, 2010 D/A
Neuralieve, Inc.
File 021-137660
$0$0$0None listed on this filingEDGAR ↗
Mar 16, 2010 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-102229
$0$0$0None listed on this filingEDGAR ↗
Nov 17, 2009 D
ADURO BIOTECH, INC.
File 021-118099
$0$0$0
Proceeds will be used for general corporate purposes.
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 8

Every issuer that named David R. Fischell on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

T
Biotechnology

TETmedical, Inc.

Fair Haven, NJ · Jun 13, 2023 → Jun 24, 2026 · 2 filings
  • Jun 24, 2026 · D · $3,533,611 sold of $9,812,108 · 45 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Jun 13, 2023 · D · $2,461,986 sold of $3,564,510 · 70 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $3.53M from 70 investors (36% of the $9.81M target) as of the latest filing. David is listed as executive officer, director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AS
Other Health Care

Ablative Solutions, Inc.

Wakefield, MA · Nov 29, 2011 → Dec 26, 2024 · 24 filings
  • Dec 26, 2024 · D · $37,158,690 sold of $45,457,118 · 88 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 30, 2024 · D/A · $29,333,042 sold of $30,000,000 · 121 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 7, 2023 · D · $12,972,761 sold of $15,000,000 · 72 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 1, 2021 · D/A · $54,462,808 sold of $91,462,993 · 105 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 8, 2019 · D · $17,462,926 sold of $77,462,992 · 104 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 2, 2018 · D · $4,010,990 sold of $10,000,000 · 24 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Mar 1, 2017 · D · $11,376,064 sold of $15,842,992 · 88 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Nov 12, 2015 · D · $2,460,000 sold of $6,500,000 · 24 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Jan 12, 2015 · D/A · $14,590,000 sold of $18,000,000 · 149 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Oct 22, 2014 · D/A · $14,300,000 sold of $17,500,000 · 144 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 7, 2014 · D · $9,575,077 sold of $12,500,000 · 100 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 7, 2013 · D/A · $7,995,000 sold of $8,000,000 · 98 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Oct 29, 2013 · D/A · $5,000,000 sold of $7,000,000 · 71 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Aug 14, 2013 · D/A · $2,705,000 sold of $5,000,000 · 41 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • May 20, 2013 · D/A · $2,000,000 sold of $2,000,000 · 30 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 4, 2013 · D · $1,050,000 sold of $1,500,000 · 13 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 26, 2012 · D · $5,369,383 sold of $5,600,000 · 72 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 29, 2012 · D/A · $3,050,500 sold of $3,200,000 · 64 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 10, 2012 · D · $990 sold of $990 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 10, 2012 · D/A · $1,462,500 sold of $2,500,000 · 34 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 24, 2012 · D · $500 sold of $500 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 4, 2012 · D · $5,000 sold of $5,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 4, 2012 · D/A · $907,500 sold of $2,500,000 · 22 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 29, 2011 · D · $457,500 sold of $1,500,000 · 12 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $54.5M from 149 investors (100% of the $45.5M target) as of the latest filing. David is listed as director, executive officer on 24 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AM
Other Health Care

Avertix Medical, Inc.

Eatontown, NJ · Dec 13, 2012 → Aug 14, 2024 · 12 filings
  • Aug 14, 2024 · D · $7,092,079 sold of $28,411,917 · 59 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 10, 2024 · D/A · $13,480,307 sold of $15,000,000 · 53 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 13, 2023 · D · $6,788,763 sold of $9,400,000 · 39 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 1, 2023 · D · $34,252,457 sold of $38,007,957 · 82 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 6, 2022 · D · $6,000,000 sold of $6,500,000 · 20 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Aug 17, 2021 · D · $3,857,162 sold of $7,500,000 · 39 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 1, 2019 · D · $10,000,000 sold of $15,000,000 · 56 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 17, 2019 · D · $600,000 sold of $2,500,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 8, 2014 · D · $10,215,000 sold of $20,500,000 · 22 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 16, 2013 · D/A · $20,531,000 sold of $20,546,000 · 23 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 3, 2013 · D/A · $17,535,000 sold of $17,535,000 · 19 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 13, 2012 · D · $3,762,500 sold of $17,525,000 · 17 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $34.3M from 82 investors (100% of the $28.4M target) as of the latest filing. David is listed as director, executive officer on 12 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

E
Other Technology

eNeura, INC.

San Jose, CA · Nov 9, 2012 → Nov 4, 2019 · 19 filings
  • Nov 4, 2019 · D · $5,909,105 sold of $6,284,105 · 15 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 12, 2019 · D · $200,000 sold of $2,000,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 12, 2019 · D/A · $15,000,000 sold of $15,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 26, 2018 · D/A · $13,451,779 sold of $17,000,000 · 40 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Feb 8, 2018 · D/A · $5,270,000 sold of $12,000,000 · 10 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Feb 8, 2018 · D · $5,270,000 sold of $12,000,000 · 24 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Jul 12, 2017 · D/A · $3,269,555 sold of $11,000,000 · 8 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Nov 30, 2016 · D · $2,169,555 sold of $5,000,000 · 3 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Mar 10, 2016 · D/A · $6,386,421 sold of $31,117,692 · 70 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Mar 12, 2015 · D/A · $5,826,421 sold of $31,117,692 · 70 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 12, 2015 · D · $15,000,000 sold of $15,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Aug 29, 2014 · D · $5,776,211 sold of $6,589,156 · 67 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 21, 2014 · D · $1,674,000 sold of $2,500,000 · 15 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jan 3, 2014 · D · $2,212,035 sold of $2,212,035 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Oct 2, 2013 · D · $589,990 sold of $1,500,000 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Aug 20, 2013 · D/A · $3,224,999 sold of $3,225,000 · 49 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 11, 2013 · D · $2,226,421 sold of $2,725,000 · 44 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 13, 2012 · D · $132,500 sold of $3,500,000 · 12 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Nov 9, 2012 · D · $1,000,000 sold of $1,600,000 · 16 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $15M from 70 investors (100% of the $6.28M target) as of the latest filing. David is listed as executive officer, director on 19 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N
Other Health Care

NeuroPace Inc

Mountain View, CA · Aug 30, 2011 → Jul 9, 2013 · 2 filings
  • Jul 9, 2013 · D · $18,051,777 sold of $50,000,006 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 30, 2011 · D · $49,126,004 sold of $61,914,481 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $72M from 26 investors (100% of the $50M target) as of the latest filing. David is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SM
Biotechnology

SVELTE MEDICAL SYSTEMS INC

New Providence, NJ · May 28, 2009 → Jun 4, 2013 · 9 filings
  • Jun 4, 2013 · D/A · $4,307,884 sold of $5,470,329 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 29, 2013 · D · $1,809,555 sold of $3,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 21, 2012 · D · $5,000,000 sold of $7,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 14, 2011 · D · $18,784,666 sold of $35,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 15, 2011 · D/A · $9,694,400 sold of $12,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 27, 2010 · D · $4,492,700 sold of $6,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 16, 2010 · D/A · $4,151,043 sold of $10,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 27, 2009 · D · $6,000,000 sold of $9,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 28, 2009 · D/A · $6,270,000 sold of $8,000,000 · 25 investors · min. $6,250 · role: Executive Officer, Director EDGAR ↗

Raised $50.4M from 39 investors (100% of the $5.47M target) as of the latest filing. David is listed as director, executive officer on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

N
Other Health Care

Neuralieve, Inc.

Sunnyvale, CA · Jan 11, 2010 → Dec 10, 2010 · 2 filings
  • Dec 10, 2010 · D/A · $7,481,174 sold of $15,500,000 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 11, 2010 · D · $3,890,652 sold of $7,500,000 · 24 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7.48M from 25 investors (48% of the $15.5M target) as of the latest filing. David is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

AB
Biotechnology

ADURO BIOTECH, INC.

Berkeley, CA · Nov 17, 2009 → Nov 17, 2009 · 2 filings
  • Nov 17, 2009 · D · $1,175,000 sold of Indefinite · 9 investors · min. $25,000 · role: Director EDGAR ↗
  • Nov 17, 2009 · D · $1,775,000 sold of $1,775,000 · 13 investors · min. $25,000 · role: Director EDGAR ↗

Raised $51.4M from 28 investors as of the latest filing. David is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around David 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

David Rosen

Director, Executive Officer · 35 shared filings (2 issuers) · also on 4 other issuers

David Rosen is on 6 issuers in total — a repeat sponsor. Their page lists every one.

PT
No photo found yet (own website and image search run after this page is viewed)
Person

Phillip D. Torrence

Executive Officer · 34 shared filings (4 issuers) · also on 1 other issuer

Phillip D. Torrence is on 5 issuers in total — a repeat sponsor. Their page lists every one.

TF
No photo found yet (own website and image search run after this page is viewed)
Person

Tim A. Fischell

Executive Officer, Director · 29 shared filings (2 issuers) · also on 3 other issuers

Tim A. Fischell is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert E. Fischell

Executive Officer, Director · 26 shared filings (4 issuers) · also on 4 other issuers

Robert E. Fischell is on 8 issuers in total — a repeat sponsor. Their page lists every one.

VG
No photo found yet (own website and image search run after this page is viewed)
Person

Vartan E. Ghazarossian

Executive Officer, Director · 16 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David R. Fischell. Their page shows their other deals.

WK
No photo found yet (own website and image search run after this page is viewed)
Person

William Kirwan

Director · 16 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Terry Lierman

Director · 16 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as David R. Fischell. Their page shows their other deals.

SA
No photo found yet (own website and image search run after this page is viewed)
Person

Steven L. Almany

Director · 15 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

ER
No photo found yet (own website and image search run after this page is viewed)
Person

Eileen O'Rourke

Director · 13 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as David R. Fischell. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Flanagan

Director · 13 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as David R. Fischell. Their page shows their other deals.

VW
No photo found yet (own website and image search run after this page is viewed)
Person

Victor Whitman

Director · 12 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Pomeranz

Executive Officer, Director · 9 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Mina Sooch

Director · 9 shared filings (1 issuer) · also on 6 other issuers

Mina Sooch is on 7 issuers in total — a repeat sponsor. Their page lists every one.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Mark A. Kielek

Executive Officer · 8 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Taylor

Executive Officer, Director · 8 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Buckman

Director · 7 shared filings (1 issuer) · also on 10 other issuers

Paul Buckman is on 11 issuers in total — a repeat sponsor. Their page lists every one.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Robert W. Croce

Director · 7 shared filings (1 issuer) · also on 11 other issuers

Robert W. Croce is on 12 issuers in total — a repeat sponsor. Their page lists every one.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

Dale Grogan

Director · 7 shared filings (1 issuer) · also on 24 other issuers

Dale Grogan is on 25 issuers in total — a repeat sponsor. Their page lists every one.

FF
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Fischer

Executive Officer, Director · 7 shared filings (2 issuers) · also on 6 other issuers

Frank Fischer is on 8 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Ross Haghighat

Director, Executive Officer · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as David R. Fischell. Their page shows their other deals.

BP
No photo found yet (own website and image search run after this page is viewed)
Person

Benjamin Pless

Director · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as David R. Fischell. Their page shows their other deals.

GP
No photo found yet (own website and image search run after this page is viewed)
Person

Geoff Pardo

Director · 5 shared filings (1 issuer) · also on 11 other issuers

Geoff Pardo is on 12 issuers in total — a repeat sponsor. Their page lists every one.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

Dan Bowen

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David R. Fischell. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Steve Burpee

Director · 5 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

MJ
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Johnson

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

DK
No photo found yet (own website and image search run after this page is viewed)
Person

David Keenan

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

John Kerschen

Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Kadir Kadhiresan

Director · 4 shared filings (1 issuer) · also on 7 other issuers

Kadir Kadhiresan is on 8 issuers in total — a repeat sponsor. Their page lists every one.

EF
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Fain

Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

SJ
No photo found yet (own website and image search run after this page is viewed)
Person

Steven R. Johnson

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

DK
No photo found yet (own website and image search run after this page is viewed)
Person

Dave Keenan

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Lisa Mastromattei

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David R. Fischell. Their page shows their other deals.

TA
No photo found yet (own website and image search run after this page is viewed)
Person

Taylor Andrew

Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Tochterman

Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

KR
No photo found yet (own website and image search run after this page is viewed)
Person

Kate Rumrill

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Fulton

Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Tom Mendell

Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Berardo

Director · 4 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald D. Bache

Director, Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as David R. Fischell. Their page shows their other deals.

DO
No photo found yet (own website and image search run after this page is viewed)
Person

David Oros

Director · 3 shared filings (1 issuer) · also on 6 other issuers

David Oros is on 7 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Same business address

8 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 8 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to David R. Fischell by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 8 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers David R. Fischell is listed on: none on file. No website or social profile named in NeuroPace Inc's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #209,794 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Mountain View, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗California — find the county court ↗Los Angeles Superior Court case search ↗Maryland Judiciary case search ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗California Secretary of State business search ↗Maryland Secretary of State business search ↗Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when David R. Fischell appears on a new Form D, or when a court case or SEC action is matched to them. See plans →